Molecular breast imaging developer Dilon Diagnostics has inked a deal to distribute GE Healthcare's Discovery NM750b molecular breast imaging system to select areas around the world.
The distribution agreement is considered an initial step in an ongoing exploration of ways the firms can provide better healthcare offerings for clinicians and their patients, the companies said.
